BioInvent International (Sweden) Profile

2.79
SEK 0.01  0.36%
2.49Last Month High 2.9 
2.77Trading Day  High 2.8 

BioInvent International Summary

BioInvent International AB (BINV) is traded on Stockholm Stock Exchange in Sweden. It is located in Lund, and employs 46 people. The company currently falls under 'Small-Cap' category with current market capitalization of 792.21 M. BioInvent International AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 304.7 M outstanding shares. BIOINVENT has accumulated about 192.77 M in cash with (75.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Check BioInvent International Probability Of Bankruptcy

BioInvent International Risk Profiles

Key Fundamentals

BioInvent International Against Markets

Current Ratings  

BioInvent International 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
24 
Chance of
< 56% 
BioInvent International AB , a researchbased pharmaceutical company, focuses on the discovery and development of antibodybased drugs against cancer. more
NameBioInvent International AB
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock Stocks Directory
Business AddressLund,
ExchangeStockholm Stock Exchange
ISINSE0000789711
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.bioinvent.com
Contact Number46 4 62 86 85 50
CurrencySEK - Swedish Kronor

Directors

BioInvent International Corporate Directors
Jonas Jendi Director
Lars Ingelmark Independent Member of the Board of Directors
Martin Nicklasson Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas